AREG and ovarian carcinoma: It has been previously reported that AREG overexpression leads to enhanced cell proliferation, migration, invasion, cancer stemness, and drug resistance in ovarian cancer (46, 47), further supporting the idea that chemotherapy results in the upregulation of genes with pro-tumorigenic implications.